Chrysalis Pharma works with the world's best teams both in chemistry in basic research.
Chrysalis -Pharma is developing a portfolio of targeted products for rare diseases, with little or no treatments available for patients.
His first and main line of development is serious lung diseases (respiratory system) with a focus on :
- Idiopathic Pulmonary Fibrosis
- Cystic Fibrosis